Markets React as Coronavirus Vaccines Get Ready to Ship

Coronavirus vaccine.
da-kuk / Getty Images/iStockphoto

Good news for those in the U.S. and our friends across the pond in the U.K. as major pharmaceutical companies are estimated to ship coronavirus vaccines soon. Early Wednesday morning, Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) issued a release stating that U.K. Regulator MHRA (the equivalent to the Food and Drug Administration in the U.S.) authorized supply of the COVID-19 mRNA vaccine for emergency use.

Find Out: Will Medicare Cover the Coronavirus Vaccine?

Despite the fact that Pfizer and BioNTech are set to deliver the first doses immediately, according to the release, global stocks didn’t exactly have a banner day: Germany’s DAX plummeted 0.3%, Euro Stoxx 50 dropped 0.2% and London’s FTSE 100 went up by a marginal 0.1%. In the U.S., however, things looked bright at market close: Pfizer stock soared by 3.55% and BioNTech skyrocketed 6.21%. Moderna (NASDAQ: MRNA) stock went up by 1.41%, as well.

Market News: Wall Street Overlooks COVID-19 Surge as Markets Rally on Vaccine Hopes

The first doses will go to older adults in nursing homes and assisting living centers, along with medical workers. The U.K. is the first in the world to approve and will be first to distribute the vaccine, starting next week. Overall, the companies have agreed to supply 40 million doses across the U.K. in 2020 and 2021.

End of the Tunnel?: The World Economy Will Be ‘Back to Normal’ By End of Next Year

Building Wealth

“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the U.K.”

Stock Trading: A Beginner’s Guide to the Markets

In the U.S., Operation Warp Speed efforts continue at, well, warp speed. The OWS project seeks to accelerate the testing, supply, development, and distribution of safe and effective COVID-19 vaccinations and treatments. Vaccines from Pfizer and Moderna await FDA approval, but an OWS document obtained by news site CNN says Pfizer could ship its first deliveries of the COVID-19 mRNA vaccine by December 15, with Moderna shipping its version on December 22. Both of these dates, of course, are pending FDA approval of the vaccines.

Building Wealth

Get In Now: Best Stocks You Can Buy for $1

It’s been widely acknowledged that a vaccine will assist with global economic recovery, but the U.S. faces challenges ahead when it comes to widespread distribution of the vaccines. U.S. governors have been instructed to complete a list of “essential tasks” by December 4. These objectives include pre-ordering vaccines from Pfizer, coordinating with healthcare providers as part of the COVID-19 vaccine program, and planning for the distribution and administration of the vaccine. Meanwhile, American debt is piling up in every state thanks to COVID-19.

More From GOBankingRates

Share this article:

Building Wealth

About the Author

Dawn Allcot is a full-time freelance writer and content marketing specialist who geeks out about finance, e-commerce, technology, and real estate. Her lengthy list of publishing credits include Bankrate, Lending Tree, and Chase Bank. She is the founder and owner of, a travel, technology, and entertainment website. She lives on Long Island, New York, with a veritable menagerie that includes 2 cats, a rambunctious kitten, and three lizards of varying sizes and personalities – plus her two kids and husband. Find her on Twitter, @DawnAllcot.
Learn More